{"slug":"tempus-ai","name":"Tempus AI, Inc.","ticker":"TEM","isPublic":true,"entityType":"company","ownership":"public","parentCompany":null,"parentSlug":null,"financials":{"revenue_2024":"$693M","market_cap":"$6.6B","revenue_raw":693000000,"market_cap_raw":6600000000},"financialsByYear":{"2023":{"revenue":"$532M","revenue_raw":532000000},"2024":{"revenue":"$693M","revenue_raw":693000000,"market_cap":"$6.6B","market_cap_raw":6600000000}},"years":{"2024":{"query":"Tempus AI competitors 2024","date":"2024-12-24","context":"Tempus AI, Inc. is a healthcare AI and precision medicine company focused on clinical AI, genomic sequencing, and data analytics for healthcare. IPO. AI-powered precision medicine platform.","sources":["Healthcare AI industry analysis"],"competitors":[{"name":"Foundation Medicine","notes":"Genomic profiling for cancer"},{"name":"Guardant Health","notes":"Liquid biopsy testing"},{"name":"Illumina","notes":"Sequencing platform provider"},{"name":"Grail","notes":"Early cancer detection AI"},{"name":"Natera","notes":"Genetic testing company"},{"name":"Caris Life Sciences","notes":"Molecular profiling"},{"name":"Flatiron Health","notes":"Oncology data analytics"},{"name":"PathAI","notes":"AI-powered pathology"}]},"2025":{"query":"Tempus AI competitors 2025","date":"2024-12-24","context":"Tempus AI, Inc. is a healthcare AI and precision medicine company focused on clinical AI, genomic sequencing, and data analytics for healthcare. Healthcare AI leader. Competing with Foundation Medicine, Illumina.","sources":["Healthcare AI industry analysis"],"competitors":[{"name":"Foundation Medicine","notes":"Roche-owned genomic testing leader"},{"name":"Guardant Health","notes":"Liquid biopsy and cancer detection"},{"name":"Illumina","notes":"Genomic sequencing hardware and services"},{"name":"Grail","notes":"Multi-cancer early detection (Illumina)"},{"name":"Natera","notes":"Cell-free DNA testing"},{"name":"Exact Sciences","notes":"Cancer screening and diagnostics"},{"name":"Flatiron Health","notes":"Roche-owned oncology data company"},{"name":"SOPHiA Genetics","notes":"AI-powered genomic analysis"}]}},"mentionedBy":[],"competitors":[{"slug":"foundation-medicine","name":"Foundation Medicine","ticker":null,"isPublic":false,"entityType":"unknown","parentSlug":null,"financials":null,"financialsByYear":null},{"slug":"guardant-health","name":"Guardant Health","ticker":null,"isPublic":false,"entityType":"unknown","parentSlug":null,"financials":null,"financialsByYear":null},{"slug":"illumina","name":"Illumina","ticker":null,"isPublic":false,"entityType":"unknown","parentSlug":null,"financials":null,"financialsByYear":null},{"slug":"grail","name":"Grail","ticker":null,"isPublic":false,"entityType":"unknown","parentSlug":null,"financials":null,"financialsByYear":null},{"slug":"natera","name":"Natera","ticker":null,"isPublic":false,"entityType":"unknown","parentSlug":null,"financials":null,"financialsByYear":null},{"slug":"caris-life-sciences","name":"Caris Life Sciences","ticker":null,"isPublic":false,"entityType":"unknown","parentSlug":null,"financials":null,"financialsByYear":null},{"slug":"flatiron-health","name":"Flatiron Health","ticker":null,"isPublic":false,"entityType":"unknown","parentSlug":null,"financials":null,"financialsByYear":null},{"slug":"uipath","name":"UiPath Inc.","ticker":"PATH","isPublic":true,"entityType":"company","parentSlug":null,"financials":{"revenue_2024":"$1.3B","market_cap":"$8B","revenue_raw":1300000000,"market_cap_raw":8000000000},"financialsByYear":{"2021":{"revenue":"$607M","revenue_raw":607000000,"market_cap":"$35B","market_cap_raw":35000000000},"2024":{"revenue":"$1.3B","revenue_raw":1300000000,"market_cap":"$8B","market_cap_raw":8000000000}}},{"slug":"exact-sciences","name":"Exact Sciences","ticker":null,"isPublic":false,"entityType":"unknown","parentSlug":null,"financials":null,"financialsByYear":null},{"slug":"sophia-genetics","name":"SOPHiA Genetics","ticker":null,"isPublic":false,"entityType":"unknown","parentSlug":null,"financials":null,"financialsByYear":null}]}